These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 2544315)

  • 21. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187.
    Bottoms GD; Johnson M; Ward D; Fessler J; Lamar C; Turek J
    Circ Shock; 1986; 20(1):25-34. PubMed ID: 3094976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
    Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG; Grigoriadis G
    J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dietary alpha-linolenic acid on endotoxin-induced production of tumor necrosis factor by peritoneal macrophages in horses.
    Morris DD; Henry MM; Moore JN; Fischer JK
    Am J Vet Res; 1991 Apr; 52(4):528-32. PubMed ID: 1675843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
    Ylikorkala O; Saarela E; Viinikka L
    J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endotoxin-induced production of interleukin 6 by equine peritoneal macrophages in vitro.
    Morris DD; Crowe N; Moore JN; Moldawer LL
    Am J Vet Res; 1992 Aug; 53(8):1298-301. PubMed ID: 1510301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a colonic PAF receptor.
    Longo WE; Carter JD; Chandel B; Niehoff M; Standeven J; Deshpande Y; Vernava AM; Polites G; Kulkarni AD; Kaminski DL
    J Surg Res; 1995 Jan; 58(1):12-8. PubMed ID: 7830400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
    Hermán F; Magyar K; Filep JG
    Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
    Mitsuhashi T; Ikata T; Morimoto K; Tonai T; Katoh S
    Paraplegia; 1994 Aug; 32(8):524-30. PubMed ID: 7970857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of platelet activating factor on TxA2, PGI2 and Ca(2+)-ATPase activity in the intra-pulmonary artery smooth muscle cells].
    Hu DH; Ma CT
    Sheng Li Xue Bao; 1996 Aug; 48(4):343-7. PubMed ID: 9389196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aprotinin decreases release of 6-keto-prostaglandin F1 alpha and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells.
    Havel MP; Griesmacher A; Weigel G; Owen A; Simon P; Müller MM; Wolner E
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):654-8. PubMed ID: 1381028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.
    Stewart AG; Phillips WA
    Br J Pharmacol; 1989 Sep; 98(1):141-8. PubMed ID: 2553184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia.
    Barton MH; Moore JN
    Circ Shock; 1994 Dec; 44(4):216-20. PubMed ID: 7628064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gossypol on phorbol ester-calcimycin-induced prostaglandin synthesis by macrophages.
    Xiao DM; Wang XL; Zhang JB; Chen HC
    Chin Med J (Engl); 1991 Apr; 104(4):321-5. PubMed ID: 2065551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.